Royal Bank of Canada’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $113K | Buy |
48,782
+18,919
| +63% | +$43.8K | ﹤0.01% | 5205 |
|
|
2025
Q1 | $233K | Buy |
29,863
+9,236
| +45% | +$72.1K | ﹤0.01% | 4247 |
|
|
2024
Q4 | $96K | Sell |
20,627
-41,459
| -67% | -$193K | ﹤0.01% | 4901 |
|
|
2024
Q3 | $334K | Sell |
62,086
-515
| -0.8% | -$2.77K | ﹤0.01% | 3992 |
|
|
2024
Q2 | $552K | Sell |
62,601
-20,135
| -24% | -$178K | ﹤0.01% | 3583 |
|
|
2024
Q1 | $973K | Buy |
82,736
+24,945
| +43% | +$293K | ﹤0.01% | 3102 |
|
|
2023
Q4 | $651K | Sell |
57,791
-14,892
| -20% | -$168K | ﹤0.01% | 3542 |
|
|
2023
Q3 | $492K | Buy |
72,683
+2,375
| +3% | +$16.1K | ﹤0.01% | 3588 |
|
|
2023
Q2 | $639K | Buy |
70,308
+9,769
| +16% | +$88.8K | ﹤0.01% | 3366 |
|
|
2023
Q1 | $391K | Hold |
60,539
| – | – | ﹤0.01% | 3722 |
|
|
2022
Q4 | $384K | Buy |
60,539
+11
| +0% | +$70 | ﹤0.01% | 3901 |
|
|
2022
Q3 | $375K | Buy |
60,528
+1,661
| +3% | +$10.3K | ﹤0.01% | 3800 |
|
|
2022
Q2 | $520K | Buy |
58,867
+7,261
| +14% | +$64.1K | ﹤0.01% | 3639 |
|
|
2022
Q1 | $434K | Buy |
51,606
+7,575
| +17% | +$63.7K | ﹤0.01% | 3928 |
|
|
2021
Q4 | $449K | Sell |
44,031
-82,380
| -65% | -$840K | ﹤0.01% | 4073 |
|
|
2021
Q3 | $2.46M | Buy |
126,411
+59,953
| +90% | +$1.16M | ﹤0.01% | 2521 |
|
|
2021
Q2 | $1.17M | Buy |
66,458
+910
| +1% | +$16K | ﹤0.01% | 3132 |
|
|
2021
Q1 | $779K | Buy |
65,548
+8,550
| +15% | +$102K | ﹤0.01% | 3382 |
|
|
2020
Q4 | $981K | Buy |
56,998
+56,894
| +54,706% | +$979K | ﹤0.01% | 3042 |
|
|
2020
Q3 | $1K | Buy |
104
+3
| +3% | +$29 | ﹤0.01% | 5941 |
|
|
2020
Q2 | $1K | Buy |
101
+11
| +12% | +$109 | ﹤0.01% | 5955 |
|
|
2020
Q1 | $0 | Buy |
+90
| New | – | ﹤0.01% | 6221 |
|
|
2019
Q4 | – | Sell |
-30
| Closed | – | – | 6263 |
|
|
2019
Q3 | $0 | Buy |
+30
| New | – | ﹤0.01% | 6073 |
|